P D Zenobi

583 total citations
9 papers, 482 citations indexed

About

P D Zenobi is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, P D Zenobi has authored 9 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Molecular Biology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in P D Zenobi's work include Growth Hormone and Insulin-like Growth Factors (8 papers), Metabolism, Diabetes, and Cancer (7 papers) and Lipid metabolism and disorders (3 papers). P D Zenobi is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (8 papers), Metabolism, Diabetes, and Cancer (7 papers) and Lipid metabolism and disorders (3 papers). P D Zenobi collaborates with scholars based in Switzerland, United Kingdom and Denmark. P D Zenobi's co-authors include E. R. Froesch, E. R. Froesch, Walter F. Riesen, Heinrich W. Ursprung, Sahara Graf, Michael Røder, T. Torresani, E A Werder, M. Zachmann and Ε. Schoenle and has published in prestigious journals such as Journal of Clinical Investigation, Diabetologia and Thrombosis and Haemostasis.

In The Last Decade

P D Zenobi

9 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P D Zenobi Switzerland	8	386	250	122	106	82	9	482
J. S. Christiansen Denmark	15	431 1.1×	108 0.4×	102 0.8×	126 1.2×	134 1.6×	29	568
K. Xiang China	11	190 0.5×	254 1.0×	97 0.8×	104 1.0×	55 0.7×	34	479
Christian Rantzau Australia	12	309 0.8×	146 0.6×	111 0.9×	121 1.1×	181 2.2×	23	523
D. Oehler United States	10	308 0.8×	171 0.7×	79 0.6×	63 0.6×	67 0.8×	11	417
E Bartolotta Italy	9	349 0.9×	121 0.5×	60 0.5×	69 0.7×	77 0.9×	22	441
Jens Møller Denmark	11	430 1.1×	95 0.4×	80 0.7×	59 0.6×	170 2.1×	18	515
Jiangming Luo Canada	11	344 0.9×	157 0.6×	52 0.4×	60 0.6×	80 1.0×	12	489
E Vilardell Spain	11	268 0.7×	113 0.5×	35 0.3×	117 1.1×	109 1.3×	39	459
H. �rskov Denmark	10	324 0.8×	178 0.7×	32 0.3×	154 1.5×	80 1.0×	12	508
Kelly L. Krass United States	9	123 0.3×	180 0.7×	98 0.8×	108 1.0×	57 0.7×	9	431

Countries citing papers authored by P D Zenobi

Since Specialization

Citations

This map shows the geographic impact of P D Zenobi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P D Zenobi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P D Zenobi more than expected).

Fields of papers citing papers by P D Zenobi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P D Zenobi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P D Zenobi. The network helps show where P D Zenobi may publish in the future.

Co-authorship network of co-authors of P D Zenobi

This figure shows the co-authorship network connecting the top 25 collaborators of P D Zenobi. A scholar is included among the top collaborators of P D Zenobi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P D Zenobi. P D Zenobi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Martin, Xavier D. & P D Zenobi. (2001). Type A Syndrome of Insulin Resistance: Anterior Chamber Anomalies of the Eye and Effects of Insulin-Like Growth Factor-I on the Retina. Ophthalmologica. 215(2). 117–123. 2 indexed citations

Zenobi, P D, et al.. (1994). Beneficial metabolic effects of insulin-like growth factor I in patients with severe insulin-resistant diabetes type A. European Journal of Endocrinology. 131(3). 251–257. 43 indexed citations

Froesch, E. R., P D Zenobi, & Mehboob A. Hussain. (1994). Metabolic and Therapeutic Effects of Insulin-Like Growth Factor I. Hormone Research. 42(1-2). 66–71. 24 indexed citations

Zenobi, P D, P. Holzmann, Yvonne Glatz, Walter F. Riesen, & E. R. Froesch. (1993). Improvement of lipid profile in Type 2 (non-insulin-dependent) diabetes mellitus by insulin-like growth factor I. Diabetologia. 36(5). 465–469. 42 indexed citations

Padayatty, Sebastian J., Stephen M. Orme, P D Zenobi, et al.. (1993). The Effects of Insulin-Like Growth Factor-1 on Plasminogen Activator Inhibitor-1 Synthesis and Secretion: Results from In Vitro and In Vivo Studies. Thrombosis and Haemostasis. 70(6). 1009–1013. 24 indexed citations

Zenobi, P D, Sahara Graf, Heinrich W. Ursprung, & E. R. Froesch. (1992). Effects of insulin-like growth factor-I on glucose tolerance, insulin levels, and insulin secretion.. Journal of Clinical Investigation. 89(6). 1908–1913. 109 indexed citations

Zenobi, P D, et al.. (1992). Insulin-like growth factor-I improves glucose and lipid metabolism in type 2 diabetes mellitus.. Journal of Clinical Investigation. 90(6). 2234–2241. 124 indexed citations

Schoenle, Ε., P D Zenobi, T. Torresani, et al.. (1991). Recombinant human insulin-like growth factor I (rhIGF I) reduces hyperglycaemia in patients with extreme insulin resistance. Diabetologia. 34(9). 675–679. 98 indexed citations

Zenobi, P D, Hans‐Peter Guler, Jürgen Zapf, & E. R. Froesch. (1988). Insulin-like growth factors in the Göttinger miniature-pig. European Journal of Endocrinology. 117(3). 343–352. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact